Editorial: HDL and cardiovascular disease: mechanisms, clinical relevance, and therapeutic impacts
Jiayou Wang, Yanqiao Zhang · 2026
Read Editorial: HDL and cardiovascular disease: mechanisms, clinical relevance, and therapeutic impacts by Jiayou Wang, Yanqiao Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13350449.txt.
Description
Jiayou Wang and Yanqiao Zhang edited a 2026 collection on HDL, the so-called good cholesterol, and cardiovascular disease. High HDL levels track with lower heart risk, yet trials that simply raised HDL with drugs failed to cut events, and genetic studies find no causal protection from the level itself.
Laboratory work still shows HDL particles directly protecting vessels and aiding metabolism in liver, immune, vessel wall, and pancreas cells. The collection shifts focus from how much HDL circulates to how well it works, gathering mechanisms, clinical relevance, and treatment ideas. Function-based measures may explain the trial disappointments and point to better targets.
Catalog record
| CREATOR | Jiayou Wang, Yanqiao Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 4167 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |